Literature DB >> 17692779

A survey of the use of foreign-purchased medications in a border community emergency department patient population.

Grace C de Guzman1, Murdoc Khaleghi, Robert H Riffenberg, Richard F Clark.   

Abstract

Many reports suggest that the use of imported medications in the United States continues to grow, fueled mostly by the rising price of prescription drugs. This trend may be problematic for several reasons, including the potential for counterfeit or impure products, a lack of pharmacist support outside of the United States, and the ability to purchase agents without a prescription from some countries. We performed a survey of Emergency Department (ED) patients in a border community to observe the magnitude of imported medication use, and to begin to determine the rationale behind the practice. A survey was conducted of 1008 ED patient encounters of individuals reporting at triage to be on any prescription or over-the-counter medication. Participants were queried on their use of imported medications and implications of such use through a questionnaire. A total of 966 patient encounter surveys were included in the analysis. Of this number, 7% reported the use of medications purchased outside of the United States. Most of these were purchased in person and in Mexico. The most commonly cited reason for importing medications was decreased cost, and almost a quarter of those importing medications stated that their physician had recommended it. The most common medications imported were antibiotics, and nearly a third of all of those buying foreign medications had done so without a prescription. Our study suggests that many patients in our community purchase medications outside of the United States.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692779     DOI: 10.1016/j.jemermed.2007.02.019

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  11 in total

1.  Binational care-seeking behavior and health-related quality of life among HIV-infected Latinos in the U.S.-Mexico border region.

Authors:  María Luisa Zúñiga; Estela Blanco; Jesse J Brennan; Rosana Scolari; Irina V Artamonova; Steffanie A Strathdee
Journal:  J Assoc Nurses AIDS Care       Date:  2010-12-24       Impact factor: 1.354

Review 2.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

3.  Heading south: why Mexican immigrants in California seek health services in Mexico.

Authors:  Steven P Wallace; Carolyn Mendez-Luck; Xóchitl Castañeda
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

4.  Antimicrobial resistance in eight US hospitals along the US-Mexico border, 2000-2006.

Authors:  S R Benoit; K D Ellingson; S H Waterman; M L Pearson
Journal:  Epidemiol Infect       Date:  2013-12-17       Impact factor: 4.434

5.  Understanding differences in prescription drug misuse between two Texas border communities.

Authors:  Priscilla Martinez; Sarah E Zemore; Miguel Pinedo; Guilherme Borges; Ricardo Orozco; Cheryl Cherpitel
Journal:  Ethn Health       Date:  2019-05-22       Impact factor: 2.732

Review 6.  Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice.

Authors:  Morton Scheinberg; Gilberto Castañeda-Hernández
Journal:  Arthritis Res Ther       Date:  2014-12-06       Impact factor: 5.156

7.  Perspectives on self-managed abortion among providers in hospitals along the Texas-Mexico border.

Authors:  Sarah Raifman; Sarah E Baum; Kari White; Kristine Hopkins; Tony Ogburn; Daniel Grossman
Journal:  BMC Womens Health       Date:  2021-03-30       Impact factor: 2.809

8.  Mexican Pharmacies and Antibiotic Consumption at the US-Mexico Border.

Authors:  Núria Homedes; Antonio Ugalde
Journal:  South Med Rev       Date:  2012-12-27

9.  Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.

Authors:  Angela M Robertson; Richard S Garfein; Karla D Wagner; Sanjay R Mehta; Carlos Magis-Rodriguez; Jazmine Cuevas-Mota; Patricia Gonzalez Moreno-Zuniga; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2014-02-12

10.  Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.

Authors:  Keith S Kaye; Vikas Gupta; Aruni Mulgirigama; Ashish V Joshi; Nicole E Scangarella-Oman; Kalvin Yu; Gang Ye; Fanny S Mitrani-Gold
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.